IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas

BACKGROUND: Mutations in isocitrate dehydrogenase (IDH)1 or -2 are found in ~50% of conventional central chondrosarcomas and in up to 87% of their assumed benign precursors enchondromas. The mutant enzyme acquires the activity to convert α-ketoglutarate into the oncometabolite d-2-hydroxyglutarate (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Sarcoma Res
Autors principals: Cleven, Arjen H. G., Suijker, Johnny, Agrogiannis, Georgios, Briaire-de Bruijn, Inge H., Frizzell, Norma, Hoekstra, Attje S., Wijers-Koster, Pauline M., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5418698/
https://ncbi.nlm.nih.gov/pubmed/28484589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-017-0074-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars